Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Dibasic potassium phosphate
Drug ID BADD_D00650
Description Dipotassium phosphate (K2HPO4) is a highly water-soluble salt often used as a fertilizer and food additive as a source of phosphorus and potassium as well as a buffering agent.
Indications and Usage Dipotassium phosphate is used in imitation dairy creamers, dry powder beverages, mineral supplements, and starter cultures as an additive. It is used in non-dairy creamers to prevent coagulation. Dipotassium phosphate is also used to make buffer solutions and it is used in the production of trypticase soy agar which is used to make agar plates for culturing bacteria.
Marketing Status approved
ATC Code Not Available
DrugBank ID DB09414
KEGG ID D02403; D02050
MeSH ID C013216
PubChem ID 24450
TTD Drug ID Not Available
NDC Product Code 0220-2962; 0220-2968; 54973-4077; 68428-456; 0220-2969; 0220-2963; 0220-2966; 58264-0132
UNII CI71S98N1Z
Synonyms potassium phosphate | potassium phosphate, unspecified form | potassium phosphate (K3-PO4) | potassium phosphate (K-H3PO4(1:2)) | potassium phosphate (K2-HPO4) | potassium monohydrogen phosphate | K2HPO4 | dipotassium hydrogen phosphate | potassium phosphate, dibasic | KD2PO4 | potassium dideuterium phosphate | potassium phosphate (K-H2PO4) | potassium phosphate, monobasic | potassium acid phosphate | potassium dihydrogen phosphate
Chemical Information
Molecular Formula K2HPO4
CAS Registry Number 7758-11-4
SMILES OP(=O)([O-])[O-].[K+].[K+]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anxiety19.06.02.002--
Asthenia08.01.01.001---
Bradycardia02.03.02.002---
Confusional state17.02.03.005; 19.13.01.001--
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.007--
Dyspnoea02.11.05.003; 22.02.01.004--
Fatigue08.01.01.002--
Feeling abnormal08.01.09.014---
Fluid retention14.05.06.002; 20.01.02.003---
Headache17.14.01.001--
Hyperkalaemia14.05.03.001--
Hypernatraemia14.05.04.001--
Hyperphosphataemia14.04.03.007--
Hypoaesthesia17.02.06.023; 23.03.03.081---
Hypocalcaemia14.04.01.004--
Hypomagnesaemia14.04.02.001--
Hypotension24.06.03.002--
Muscle spasms15.05.03.004--
Myocardial infarction02.02.02.007; 24.04.04.009--
Nephrocalcinosis20.04.01.001---
Oedema peripheral02.05.04.007; 08.01.07.007; 14.05.06.011--
Oliguria20.01.03.004---
Pain08.01.08.004--
Paraesthesia17.02.06.005; 23.03.03.094--
Pollakiuria20.02.02.007--
Seizure17.12.03.001--
Sensory loss17.02.07.007---
Swelling08.01.03.015---
Tachycardia02.03.02.007---
Thirst08.01.09.021; 14.03.02.007---
The 1th Page    1 2    Next   Last    Total 2 Pages